The AABB website is currently experiencing technical issues related to login and SSO. Thank you for your patience as we work to get this resolved. If you need immediate assistance, please contact us.
Newsfeed
AABB's Newsfeed is an essential resource offering the latest news, analysis, commentary and updates on critical topics for the blood and biotherapies community.
The regulation of laboratory-developed tests (LDTs) is beyond the legal authority of the U.S. Food and Drug Administration, according to a ruling issued today by a federal judge.
Peter Marks, MD, PhD, head of FDA’s Center for Biologics Evaluation and Research, will resign from the agency, effective April 5. His resignation comes amid a broader shakeup in the nation’s health agencies led by HHS Secretary Robert F. Kennedy, Jr.
AABB is pleased to announce a new collaboration with Cord Blood Connect, the annual meeting of the Cord Blood Association (CBA). CBC will take place as part of the 2025 AABB Annual Meeting, to be held Oct. 25-28 in San Diego.
Separating plasma from other blood components before transfusion may improve outcomes for patients with traumatic brain injury (TBI) or shock, according to new findings from the University of Pittsburgh School of Medicine and UPMC.
The U.S. Department of Health and Human Services announced a major restructuring on Thursday aimed at improving efficiency and streamlining operations. According to government estimates, these changes could save $1.8 billion annually.
The Federal Bureau of Investigation has determined that there is no specific credible threat targeting hospitals in any U.S. city, according to an update from the American Hospital Association and Health-ISAC.
The Health Resources and Services Administration (HRSA) renewed the charter for the Advisory Council on Blood Stem Cell Transplantation (ACBSCT), effective Feb. 19.
The Senate confirmed Marty Makary, MD, MPH, FACS, to serve as the next commissioner of food and drugs and and Jay Bhattacharya, MD, PhD, as the next director of the National Institutes of Health (NIH).
Out of an abundance of caution, the American Hospital Association and Health-ISAC issued a joint threat bulletin last week alerting hospitals to a social media post referencing an active plan for a coordinated, multi-city terrorist attack on hospitals.
President Donald Trump nominated Susan Monarez, PhD, a health scientist and the agency's acting director, to serve as the next director of the Centers for Disease Control and Prevention.
